# A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

> **NCT00384397** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1128 (actual)

## Conditions studied

- Meningococcal Meningitis
- Measles
- Mumps
- Rubella
- Varicella

## Interventions

- **BIOLOGICAL:** Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine
- **BIOLOGICAL:** Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
- **BIOLOGICAL:** Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

## Key facts

- **NCT ID:** NCT00384397
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-08
- **Final completion:** 2009-02
- **Target enrollment:** 1128 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384397, "A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00384397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*